Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.49 USD | +1.34% |
|
+8.16% | +0.03% |
14/06 | Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva... | ![]() |
14/06 | Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym | MT |
Business Summary
Number of employees: 352
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 402 | 100.0 % | 482 | 100.0 % | +20.04% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 402 | 100.0 % | 482 | 100.0 % | +20.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 13/98/13 |
Atabak Mokari
DFI | Director of Finance/CFO | 47 | 01/21/01 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 46 | 01/12/01 |
Hazel Hunt
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/11/01 |
Jerry Pan
IRC | Investor Relations Contact | - | 01/21/01 |
Amy E. Flood
IRO | Public Communications Contact | - | 12/21/12 |
William Guyer
PRN | Corporate Officer/Principal | 56 | 16/21/16 |
Monica Tellado
PRN | Corporate Officer/Principal | 51 | 01/11 |
Sean Maduck
PRN | Corporate Officer/Principal | 47 | 01/12/01 |
Gary Robb
SEC | Corporate Secretary | 61 | 01/11/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 13/98/13 |
Gregg Alton
BRD | Director/Board Member | 58 | 12/20/12 |
George Baker
BRD | Director/Board Member | 81 | 01/99/01 |
James Wilson
CHM | Chairman | 80 | 01/99/01 |
David Mahoney
BRD | Director/Board Member | 69 | 01/04/01 |
Daniel Swisher
BRD | Director/Board Member | 61 | 18/15/18 |
Kimberly Park
BRD | Director/Board Member | 60 | 18/19/18 |
Gillian Cannon
BRD | Director/Board Member | 60 | 23/20/23 |
Joshua Murray
BRD | Director/Board Member | 40 | 09/21/09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 135,312,088 | 92,257,207 ( 68.18 %) | 31,200,000 ( 23.06 %) | 68.18 % |
Company contact information
Corcept Therapeutics, Inc.
149 Commonwealth Drive
94025, Menlo Park
+650 327 3270
http://www.corcept.com![address Corcept Therapeutics Incorporated(CORT)](https://cdn.zonebourse.com/static/address/40449488.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.03% | 338.26Cr | |
+55.32% | 82TCr | |
+44.05% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr |
- Stock Market
- Equities
- CORT Stock
- Company Corcept Therapeutics Incorporated